Skip to content
Medical Health Aged Care, Women

Study underlines the importance of supporting primary care clinicians to deliver early medical abortion and long acting reversible contraception

Monash University 2 mins read

The impetus for additional support and training for clinicians wanting to deliver important sexual and reproductive services has received a boost with the release of Monash University-led research.

Published in BMJ – Sexual and Reproductive Health, the AusCAPPS study found that GPs, nurses and pharmacists seek peer support and online resources to deliver long-acting reversible contraception (LARC) and early medical abortion (EMA) in Australian primary care.

Experienced and emerging providers of LARC and EMA sought support regarding clinical issues online from AusCAPPS, which is the Australian Contraception and Abortion Primary Care Practitioner Support Network, an evidence-based virtual community of practice launched by the SPHERE Centre of Research Excellence in July 2021.

This research confirmed the importance of the Network.

AusCAPPS was recently funded for a further 2.5 years as part of the Federal Government’s commitment to supporting women’s health in primary care, to support GPs, nurses and pharmacists who want to provide LARC and EMA in primary care.

Uptake of LARC is lower in Australia (11 per cent) compared with other high-income countries (>30 per cent). Additionally, with only about 11 per cent of GPs providing EMA, women's access to these services are greatly dependent on where they live,” explained first author GP and SPHERE Centre of Excellence research fellow, Dr Sonia Srinivasan.

“Our study found that primary care clinicians are looking for practical and professional support to provide LARC and EMA. GPs want to boost their clinical knowledge with input from peers and experts, nurses are looking for ways to overcome the challenges faced delivering these services in clinical practice and pharmacists seek clarity around the regulations that guide the dispensing of drugs.”

The paper explained that barriers to primary care provision of LARC and EMA include a lack of provider education and training opportunities, inadequate support and stigma. LARC and EMA services are concentrated in metropolitan areas, and high out-of-pocket costs create additional barriers for young, rural and remote Australian women in particular.

The AusCAPPS Network, which has more than 2600 members (60 per cent are GPs, 14 per cent nurses, and 22 per cent pharmacists), is used extensively by participants and welcomes new members. 

The study, which surveyed 2021-2023 AusCAPPS members, found that health professional peer support, point-of-care patient guides and educational webinars and podcasts were crucial online tools that supported GPs, nurses and pharmacists to deliver local LARC and EMA services.

In order to increase women’s access to these essential reproductive health services, we need more GPs, nurses and pharmacists involved in the provision of LARC and EMA,” Dr Srinivasan said. Our research demonstrates what GPs, nurses and pharmacists actually need in practice to support this objective.”

This research, undertaken with the support of the Royal Australian College of General Practitioners (RACGP) Foundation, builds on a range of research and initiatives by SPHERE and AusCAPPS to build the capacity of primary care to deliver Early Medical Abortion and Long Acting Reversible Contraception, including in rural and remote communities.

Read the full paper in BMJ Sexual and Reproductive Health:
What do Australian primary care clinicians need to provide long-acting reversible contraception and early medical abortion? A content analysis of a virtual community of practice 

DOI:  10.1136/bmjsrh-2024-202330

For media enquiries please contact:

Monash University

Cheryl Critchley – Media and Communications Manager (medical)
E:
[email protected]

T: +61 (0) 477 571 442

 

For more Monash media stories, visit our news and events site 


For general media enquiries please contact:
Monash Media
E: 
[email protected]
T: +61 (0) 3 9903 4840

 

***ENDS***

 

More from this category

  • LGBTQIA, Medical Health Aged Care
  • 12/01/2026
  • 13:36
Health Equity Matters

Long-acting HIV PrEP registration brings us another step closer to ending HIV for Australia, but access remains a barrier

Long-acting HIV PrEP registration brings us another step closer to ending HIV for Australia, but access remains a barrier Health Equity Matters has welcomed the registration of the long-acting PrEP option Lencapavir by Australia’s Therapeutic Goods Administration, with the drug having the potential to significantly bolster HIV prevention in Australia. Lencapavir is the second drug of its kind to be registered in Australia, but neither has been made available to the community yet. Health Equity Matters has acknowledged that the registration of this tool to reduce transmission is an excellent development, but that making these long-acting options available and affordable…

  • Medical Health Aged Care
  • 12/01/2026
  • 11:00
Australian Primary Health Care Nurses Association (APNA)

Building on bulk billing impacts can make primary health care nurses even more effective

The Australian Primary Health Care Nurses Association(APNA)has today welcomednewsthat bulk billing incentives are improving access to primary health care. “As primary health care nurses,we'repassionate about health equity, and making sure that peoplecan get affordable andequitableaccess to primary health care” said APNA President Denise Lyons. “The government’s bulk billing incentives areimportantinsupporting people to access the care they need. “Primary health care nursesare highly educated and experienced. They forma critical part of general practice teams, regularly undertakingimmunisation,wound care, care planning and coordination, and so much more. “If break down barriers,primary health care nursescan do even more.We want to see reforms thatimplement the…

  • Medical Health Aged Care
  • 09/01/2026
  • 23:40
Dark Horse Consulting Group

Bruder Consulting & Venture Group to become Dark Horse Consulting Regenerative Medicine

WALNUT CREEK, Calif. and NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational biotherapeutics consulting, is pleased to announce the acquisition of Bruder Consulting & Venture Group (“Bruder” or “BCVG”), a strategic advisory and consulting firm with a global footprint in biotech and biopharma, known for their expertise in the discovery, development, clinical design, and regulatory approval process of biologics, devices and combination products in the orthopedic, wound care, and plastic & reconstructive surgery markets. BCVG is now a department within Dark Horse Consulting (DHC) known as…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.